Alogliptin Benzoate 5 mg | Purity Not Available
TargetMol
Alogliptin Benzoate(SYR 322), an effective and specific DPP-4 inhibitor (IC50
More Information Supplier PageAlogliptin Benzoate
Search Results
Edoxaban Tosylate Monohydrate 100 mg | Purity Not Available
TargetMol
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
More Information Supplier PageEdoxaban Tosylate Monohydrate
BRD7116 5 mg | 99.30%
TargetMol
BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.
More Information Supplier PageBRD7116
BRD7116 25 mg | 99.30%
TargetMol
BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.
More Information Supplier PageBRD7116
BRD7116 10 mg | 99.30%
TargetMol
BRD7116 competitively binds to bacterial DNA gyrase, with cell-non-autonomous anti-leukemia activity.
More Information Supplier PageBRD7116
AMI-1 5 mg | 99.90%
TargetMol
AMI-1 is an effective and selective Histone Methyltransferase (HMT) inhibitor (IC50: 3.0/8.8 μM, for yeast Hmt1p, and human PRMT1).
More Information Supplier PageAMI-1
AMI-1 25 mg | 99.90%
TargetMol
AMI-1 is an effective and selective Histone Methyltransferase (HMT) inhibitor (IC50: 3.0/8.8 μM, for yeast Hmt1p, and human PRMT1).
More Information Supplier PageAMI-1
Edoxaban Tosylate Monohydrate 10 mg | Purity Not Available
TargetMol
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
More Information Supplier PageEdoxaban Tosylate Monohydrate
Edoxaban Tosylate Monohydrate 25 mg | Purity Not Available
TargetMol
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
More Information Supplier PageEdoxaban Tosylate Monohydrate
Edoxaban Tosylate Monohydrate 5 mg | Purity Not Available
TargetMol
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
More Information Supplier PageEdoxaban Tosylate Monohydrate